Enhanced absorption and drug targeting by positively charged submicron emulsions

Drug Development Research

Volumn 50, Issue 3-4, 2000, Pages 476-486

  Yang, Shi Cheng ^a   Benita, Simon ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Absorption; Biodistribution; Positive charge; Review; Submicron emulsions; Targeting

Indexed keywords

ATROPINE; CYCLOSPORIN A; EMULSIFYING AGENT; INDOMETACIN; INTRALIPID; LIPID; LIPOFUNDIN; MENATETRENONE; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER; PROGESTERONE; RHIZOXIN; SURFACTANT; TACROLIMUS; TIMOLOL; WATER OIL CREAM;

CANCER CHEMOTHERAPY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG STABILITY; DRUG TARGETING; DRUG UPTAKE; HUMAN; LIPOPHILICITY; LUNG CANCER; MICROEMULSION; NONHUMAN; PARTICLE SIZE; PARTITION COEFFICIENT; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 0033815462     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200007/08)50:3/4<476::AID-DDR31>3.0.CO;2-6     Document Type: Review

References (68)

1. Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions
2. Prevention of topical and ocular oxidative stress by positively charged submicron emulsion
3. Submicron emulsions as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization
4. Physostigmine emulsion: A new injectable controlled release delivery system
5. Improved ocular bioavailability of indomethacin by novel ocular drug carriers
6. Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicro-emulsions
7. Self-emulsifying drug delivery systems: Formulation and biopharmaceutic evaluation of an investigational lipophilic compound
8. Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects
9. The stability of fat emulsions for intravenous administration
10. Lipid emulsions as drug delivery systems
11. Studies on the interaction of charge reversed emulsions with the reticuloendothelial system
12. Positively-charged submicron emulsions - A new type of colloidal drug carrier
13. Prevention of oxidative damage in fibroblast cell cultures and rat skin by positively-charged submicron emulsion of α-tocopherol
14. Systemic side effects from ophthalmic timolol and their prevention
15. Effect of parenteral fat emulsion on the pulmonary and reticuloendothetial systems in the newborn infants
16. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone
17. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge
18. Control of the rate of hepatic uptake and metabolism of liposome-entrapped proteins injected into rats
19. In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector
20. Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsion formulations
21. The influence of free fatty acid formation on the pH of phospholipid-stabilized triglyceride emulsions
22. Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats
23. Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process
24. O/W lipid inicroemulsion for parenteral drug delivery
25. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group
26. Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration
27. Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle
28. The stability of piroxicam incorporated in a positively-charged submicron emulsion for ocular administration
29. Emulsions as drug carriers - Possibilities, limitations and future perspectives
30. Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn
31. Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution
32. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery
33. Systemic absorption and cardiovascular effects of phenylephrine eyedrops
34. Lipid emulsions of palmitoylrhizoxin: Effects of particle size on blood dispositions of emulsion lipid and incorporated compound in rats
35. Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats
36. Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice
37. Ocular drug delivery: Conventional ocular formulations
38. Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338
39. Fate of cationic liposomes and their complex with oligonucleotide in vivo
40. Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs
41. Cationic lipid-base gene delivery systems: Pharmaceutical perspectives
42. Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine
43. Emulsions as drug carriers for ophthalmic use
44. Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea
45. Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits
46. Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors
47. Ocular side effects of indomethacin
48. Permeability of cornea, sclera and conjunctiva: A literature analysis for drug delivery to the eye
49. Structure of DNA-cationic liposome complexes: DNA interaction in multilamellar membranes in distinct interhelical packing regimes
50. Emulsions
51. Transport mechanisms of the cornea: Characterization of barrier permselectivity
52. The function of phospholially water insoluble cytotoxic agent
53. O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection
54. Enzymes and microemulsions. Activity and kinetic properties of liver alcohol dehydro-genase in ionic water-in-oil microemulsions
55. Enzyme therapy VI: Comparative in vivo fates and effects on lysosomal integrity of enzymes entrapped in negatively and positively charged liposomes
56. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations
57. Long circulating emulsion carrier systems for highly lipophilic drugs
58. Determination of the pH-dependent phase distribution of prostaglandin El in a lipid emulsion by ultrafiltration
59. Submicron cationic emulsions as a new delivery system for oligonucleotides
60. Mieroemulsions: An overview and pharmaceutical applications
61. Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route
62. Intravascular metabolism of an artificial transporter of triacylglycerols
63. Fat emulsion as a vehicle for diazepam. A study of 9492 patients
64. Aging effects in parenteral fat emulsions: The role of fatty acids
65. Sequential statistical optimization of a positively-charged submicron emulsion of miconazole
66. Stability assessment of emulsions systems
67. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs
68. The design and characterization of a positively-charged submicron emulsion containing a sunscreen agent